Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type |
A1 | 1 | 14 | F | Liver | Liver tissue | * | * | * | Normal |
A2 | 2 | 55 | F | Liver | Hepatocellular carcinoma | 1 | T3N0M0 | IIIA | Malignant |
A3 | 3 | 65 | M | Liver | Cancer adjacent cirrhosis tissue | * | * | * | Hyperplasia |
A4 | 4 | 46 | M | Liver | Adjacent cirrhosis tissue | * | * | * | Hyperplasia |
A5 | 5 | 38 | M | Liver | Hepatocellular carcinoma | 1 | T3N0M0 | IIIA | Malignant |
A6 | 6 | 69 | F | Liver | Cancer adjacent chronic hepatitis tissue | * | * | * | Inflammation |
A7 | 7 | 35 | M | Liver | Liver tissue | * | * | * | Normal |
A8 | 8 | 58 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant |
A9 | 9 | 58 | M | Liver | Cancer adjacent cirrhosis tissue | * | * | * | Hyperplasia |
B1 | 10 | 65 | M | Liver | Adjacent normal liver tissue | * | * | * | NAT |
B2 | 11 | 58 | M | Liver | Hepatocellular carcinoma | 2 | T3N1M0 | IVA | Malignant |
B3 | 12 | 47 | M | Liver | Cancer adjacent chronic hepatitis tissue | * | * | * | Inflammation |
B4 | 13 | 48 | M | Liver | Adjacent cirrhosis tissue | * | * | * | Hyperplasia |
B5 | 14 | 49 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant |
B6 | 15 | 49 | M | Liver | Cancer adjacent cirrhosis tissue of No.14 | * | * | * | Hyperplasia |
B7 | 16 | 57 | F | Liver | Adjacent chronic hepatitis tissue | * | * | * | Inflammation |
B8 | 17 | 41 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant |
B9 | 18 | 41 | M | Liver | Cancer adjacent cirrhosis tissue of No. 17 | * | * | * | Hyperplasia |
C1 | 19 | 25 | F | Liver | Adjacent normal liver tissue | * | * | * | NAT |
C2 | 20 | 48 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant |
C3 | 21 | 48 | M | Liver | Cancer adjacent chronic hepatitis tissue of No. 20 | * | * | * | Inflammation |
C4 | 22 | 56 | F | Liver | Adjacent chronic hepatitis tissue | * | * | * | Inflammation |
C5 | 23 | 39 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant |
C6 | 24 | 39 | M | Liver | Cancer adjacent cirrhosis tissue of No. 23 | * | * | * | Hyperplasia |
C7 | 25 | 66 | M | Liver | Adjacent chronic hepatitis tissue | * | * | * | Inflammation |
C8 | 26 | 33 | M | Liver | Hepatocellular carcinoma | 3 | T3N0M0 | IIIA | Malignant |
C9 | 27 | 50 | F | Liver | Cancer adjacent cirrhosis tissue | * | * | * | Hyperplasia |
D1 | 28 | 63 | M | Liver | Adjacent cirrhosis tissue | * | * | * | Hyperplasia |
D2 | 29 | 32 | F | Liver | Hepatocellular carcinoma | 2 | T3N0M0 | IIIA | Malignant |
D3 | 30 | 63 | M | Liver | Cancer adjacent fatty degeneration of liver cells | * | * | * | Hyperplasia |
D4 | 31 | 50 | M | Liver | Adjacent cirrhosis tissue | * | * | * | Hyperplasia |
D5 | 32 | 40 | M | Liver | Hepatocellular carcinoma | 2 | T3N0M0 | IIIA | Malignant |
D6 | 33 | 40 | M | Liver | Cancer adjacent cirrhosis tissue of No. 32 | * | * | * | Hyperplasia |
D7 | 34 | 46 | M | Liver | Adjacent normal liver tissue | * | * | * | NAT |
D8 | 35 | 65 | M | Liver | Clear cell type hepatocellular carcinoma | * | T3N0M0 | IIIA | Malignant |
D9 | 36 | 40 | F | Liver | Cancer adjacent chronic hepatitis tissue | * | * | * | Inflammation |
E1 | 37 | 63 | M | Liver | Adjacent normal liver tissue | * | * | * | NAT |
E2 | 38 | 46 | M | Liver | Hepatocellular carcinoma | 2 | T1N0M0 | I | Malignant |
E3 | 39 | 63 | F | Liver | Cancer adjacent liver tissue | * | * | * | AT |
E4 | 40 | 66 | F | Liver | Adjacent liver tissue (cataplasia) | * | * | * | NAT |
E5 | 41 | 98 | F | Liver | Hepatocellular carcinoma | 2 | T3N0M0 | IIIA | Malignant |
E6 | 42 | 43 | M | Liver | Cancer adjacent cirrhosis tissue | * | * | * | Hyperplasia |
E7 | 43 | 64 | M | Liver | Adjacent chronic hepatitis tissue | * | * | * | Inflammation |
E8 | 44 | 64 | M | Liver | Hepatocellular carcinoma of No. 43 | 2 | T3N0M0 | IIIA | Malignant |
E9 | 45 | 64 | M | Liver | Cancer adjacent cirrhosis tissue of No. 43 | * | * | * | Hyperplasia |
F1 | 46 | 56 | M | Liver | Adjacent chronic hepatitis tissue | * | * | * | Inflammation |
F2 | 47 | 57 | M | Liver | Hepatocellular carcinoma | 2--3 | T2N0M0 | II | Malignant |
F3 | 48 | 57 | M | Liver | Cancer adjacent cirrhosis tissue of No. 47 | * | * | * | Hyperplasia |
F4 | 49 | 37 | F | Liver | Adjacent normal liver tissue | * | * | * | NAT |
F5 | 50 | 39 | M | Liver | Hepatocellular carcinoma | * | * | * | Malignant |
F6 | 51 | 55 | M | Liver | Adjacent cirrhosis tissue | * | * | * | Hyperplasia |
F7 | 52 | 62 | F | Liver | Adjacent chronic hepatitis tissue | * | * | * | Inflammation |
F8 | 53 | 62 | F | Liver | Hepatocellular carcinoma of No. 52 | 2--3 | T3N0M0 | IIIA | Malignant |
F9 | 54 | 62 | F | Liver | Cancer adjacent chronic hepatitis tissue of No. 52 | * | * | * | Inflammation |
G1 | 55 | 55 | M | Liver | Adjacent normal liver tissue | * | * | * | NAT |
G2 | 56 | 56 | M | Liver | Hepatocellular carcinoma | 3 | T3N0M0 | IIIA | Malignant |
G3 | 57 | 56 | M | Liver | Cancer adjacent liver tissue of No. 56 | * | * | * | AT |
G4 | 58 | 56 | M | Liver | Adjacent normal liver tissue | * | * | * | NAT |
G5 | 59 | 70 | F | Liver | Intrahepatic bile duct cell carcinoma with necrosis | 2 | T2N0M0 | II | Malignant |
G6 | 60 | 70 | F | Liver | Cancer adjacent chronic hepatitis tissue of No. 59 | * | * | * | Inflammation |
G7 | 61 | 66 | M | Liver | Adjacent chronic hepatitis tissue | * | * | * | Inflammation |
G8 | 62 | 66 | M | Liver | Cholangiocellular carcinoma of No. 61 | 1 | T2N0M0 | II | Malignant |
G9 | 63 | 66 | M | Liver | Cancer adjacent cirrhosis tissue of No. 61 | * | * | * | Hyperplasia |
H1 | 64 | 71 | M | Liver | Adjacent normal liver tissue | * | * | * | NAT |
H2 | 65 | 71 | M | Liver | Cholangiocellular carcinoma of No. 64 | 1 | T3N0M0 | IIIA | Malignant |
H3 | 66 | 71 | M | Liver | Cancer adjacent chronic hepatitis tissue of No. 64 | * | * | * | Inflammation |
H4 | 67 | 52 | F | Liver | Adjacent chronic hepatitis tissue | * | * | * | Inflammation |
H5 | 68 | 40 | F | Liver | Cholangiocellular carcinoma (sparse) | * | T3N0M0 | IIIA | Malignant |
H6 | 69 | 43 | M | Liver | Cancer adjacent cirrhosis tissue | * | * | * | Hyperplasia |
H7 | 70 | 58 | F | Liver | Adjacent normal liver tissue | * | * | * | NAT |
H8 | 71 | 58 | F | Liver | Cholangiocellular carcinoma of No. 70 | 1--2 | T2N0M0 | II | Malignant |
H9 | 72 | 58 | F | Liver | Cancer adjacent chronic hepatitis tissue of No. 70 | * | * | * | Inflammation |
Tissue Marker |